Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805
Shots:
- Just-Evotec to leverage its technology platform- J.Design to accelerate OncoResponse’s OR2805 through the development and into the clinic
- Just-Evotec provides services to the OncoResponse which includes cell line development- process development- and P-I/II cGMP clinical manufacturing of OR2805 in human clinical studies
- OncoResponse’s OR2805 is an Ab- reversing the immunosuppression in the tumor microenvironment and promoting cancer-killing- leading to higher response rates
Click here to read full press release/ article | Ref: Evotec | Image: Canaan
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
